Senior Vice President, Worldwide Head of Medical Affairs, Immunology & Cardiovascular

Role Summary

Senior Vice President, Worldwide Head of Immunology & Cardiovascular (ICV) Medical Affairs. Defines global medical vision, strategy, and execution across immunology, inflammation, cardiovascular disease, and cardiometabolic conditions. This mission-defining enterprise role operates across early development through lifecycle maturity, shaping evidence, influencing global practice, and delivering practice-changing, equitable impact for patients worldwide. As the senior-most medical leader for ICV, the role sits on the Worldwide Medical Leadership Team and partners with R&D, Commercial, Market Access, and Policy to serve as the global medical face of BMS to regulators, academia, professional societies, and patient communities.

Responsibilities

• Define and execute an integrated global medical strategy across Immunology & Cardiovascular aligned to enterprise priorities, patient imperatives, and portfolio value creation.
• Serve as a senior enterprise advisor, shaping clinical development, regulatory strategy, evidence generation, and commercialization from early pipeline through mature brands.
• Anticipate and navigate evolving scientific, regulatory, payer, and competitive landscapes, positioning BMS as a global leader in immune-mediated and cardiovascular disease innovation.
• Contribute to portfolio strategy, prioritization, and investment decisions, including lifecycle expansion, indication strategy, and external innovation.
• Partner with R&D to shape early development strategies, including trial design, endpoints, biomarkers, and translational approaches aligned with real-world standards of care.
• Drive early signal-seeking and differentiation strategies to de-risk assets and expand pipeline and lifecycle value.
• Integrate clinical trial data, real-world evidence, and medical insights to deliver scientifically differentiated narratives that inform practice and policy.
• Support scientific diligence for external opportunities, partnerships, and acquisitions.
• Lead the design and execution of integrated global evidence plans across the ICV portfolio, spanning interventional studies, RWE, registries, and observational research.
• Ensure evidence strategies support regulatory success, reimbursement, access, guideline inclusion, and practice change.
• Embed the patient journey and lived experience into evidence planning, ensuring relevance across diverse populations and healthcare systems.
• Partner closely with HEOR, Market Access, Clinical Development, and Commercial teams to align scientific, economic, and outcomes-based narratives.
• Lead a high-performing, globally distributed medical organization, fostering a culture of accountability, scientific rigor, inclusion, and execution excellence.
• Implement globally aligned, fit-for-purpose operating models that enable speed, focus, and measurable impact.
• Leverage digital innovation, advanced analytics, and GenAI-enabled insights to elevate decision-making, insight generation, and external engagement.
• Establish outcome-based metrics to ensure medical activities deliver tangible patient, practice, and enterprise impact.
• Champion timely, appropriate, and equitable access to ICV therapies across major and emerging markets.
• Partner with advocacy groups, policymakers, and health systems to address disparities in immune-mediated and cardiovascular care.
• Ensure medical strategy proactively supports access pathways, including early access, real-world evidence needs, and health system readiness.
• Serve as the global medical voice of BMS Immunology & Cardiovascular, engaging regulators, academic leaders, professional societies, and patient organizations.
• Build and lead strategic external collaborations that accelerate innovation, evidence generation, and global impact.
• Strengthen BMS's scientific reputation through credible, visible, and influential leadership in the global ICV community.

Qualifications

• MD (or MD/PhD) with deep expertise in Immunology, Rheumatology, Cardiology, Cardiovascular Medicine, or a closely related discipline.
• 15+ years of progressive leadership experience in biopharma and/or academic medicine with significant global medical or development responsibility.
• Demonstrated leadership across early and late-stage development, regulatory interactions, medical launch excellence, and lifecycle management.
• Recognized scientific credibility, including publications, guideline involvement, or leadership within professional societies.
• Proven ability to lead large, global, matrixed organizations and operate effectively at enterprise executive level.
• Exceptional executive presence, communication, and influence skills with internal and external stakeholders.
• Experience across major markets and global roles required; R&D experience strongly preferred.

Skills

• Accountability: Clear ownership and decisive leadership
• Execution Excellence: Focus, urgency, and disciplined delivery
• Enterprise Mindset: Balancing patient impact with business value
• Scientific Leadership: Shaping the future of care through evidence and insight
• Patient-Centricity: Unwavering commitment to improving lives
• Executive presence, communication, and influence with internal and external stakeholders
• Experience leading large, global, matrixed organizations and operating at enterprise executive level